Ding Xunshan, Lichti Kristin, Kim Insook, Gonzalez Frank J, Staudinger Jeff L
Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas 66045, USA.
J Biol Chem. 2006 Sep 8;281(36):26540-51. doi: 10.1074/jbc.M600931200. Epub 2006 Jul 5.
Animal studies reveal that fasting and caloric restriction produce increased activity of specific metabolic pathways involved in resistance to weight loss in liver. Evidence suggests that this phenomenon may in part occur through the action of the constitutive androstane receptor (CAR, NR1I3). Currently, the precise molecular mechanisms that activate CAR during fasting are unknown. We show that fasting coordinately induces expression of genes encoding peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), CAR, cytochrome P-450 2b10 (Cyp2b10), UDP-glucuronosyltransferase 1a1 (Ugt1a1), sulfotransferase 2a1 (Sult2a1), and organic anion-transporting polypeptide 2 (Oatp2) in liver in mice. Treatments that elevate intracellular cAMP levels also produce increased expression of these genes in cultured hepatocytes. Our data show that PGC-1alpha interaction with hepatocyte nuclear factor 4alpha (HNF4alpha, NR2A1) directly regulates CAR gene expression through a novel and evolutionarily conserved HNF4-response element (HNF4-RE) located in its proximal promoter. Expression of PGC-1alpha in cells increases CAR expression and ligand-independent CAR activity. Genetic studies reveal that hepatic expression of HNF4alpha is required to produce fasting-inducible CAR expression and activity. Taken together, our data show that fasting produces increased expression of genes encoding key metabolic enzymes and an uptake transporter protein through a network of interactions involving cAMP, PGC-1alpha, HNF4alpha, CAR, and CAR target genes in liver. Given the recent finding that mice lacking CAR exhibit a profound decrease in resistance to weight loss during extended periods of caloric restriction, our findings have important implications in the development of drugs for the treatment of obesity and related diseases.
动物研究表明,禁食和热量限制会使肝脏中参与抵抗体重减轻的特定代谢途径的活性增加。有证据表明,这种现象可能部分是通过组成型雄烷受体(CAR,NR1I3)的作用而发生的。目前,禁食期间激活CAR的确切分子机制尚不清楚。我们发现,禁食可协同诱导小鼠肝脏中编码过氧化物酶体增殖物激活受体γ共激活因子-1α(PGC-1α)、CAR、细胞色素P-450 2b10(Cyp2b10)、尿苷二磷酸葡萄糖醛酸基转移酶1a1(Ugt1a1)、磺基转移酶2a1(Sult2a1)和有机阴离子转运多肽2(Oatp2)的基因表达。提高细胞内cAMP水平的处理也会使这些基因在培养的肝细胞中表达增加。我们的数据表明,PGC-1α与肝细胞核因子4α(HNF4α,NR2A1)的相互作用通过位于其近端启动子中的一个新的且在进化上保守的HNF4反应元件(HNF4-RE)直接调节CAR基因的表达。细胞中PGC-1α的表达增加了CAR的表达和不依赖配体的CAR活性。遗传学研究表明,HNF4α的肝脏表达是产生禁食诱导的CAR表达和活性所必需的。综上所述,我们的数据表明,禁食通过涉及cAMP、PGC-1α、HNF4α、CAR和肝脏中CAR靶基因的相互作用网络,使编码关键代谢酶和一种摄取转运蛋白的基因表达增加。鉴于最近的发现,即缺乏CAR的小鼠在长期热量限制期间对体重减轻的抵抗力显著降低,我们的研究结果对肥胖及相关疾病治疗药物的开发具有重要意义。